On 6/28/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 20.6%, closing at $11.93. Moreover, exceptionally high trading volume at 1193% of normal accompanied the advance. The stock has risen 10.1% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment